COVID-19 among patients with giant cell arteritis: a single-centre observational study from SloveniaReview Published on 2022-08-012023-07-08 Journal: Clinical Rheumatology [Category] COVID19(2023년), [키워드] COVID-19 giant cell arteritis Glucocorticoids leflunomide outcome assessment [DOI] 10.1007/s10067-022-06157-4 PMC 바로가기 [Article Type] Review
Treatment with 3-day methylprednisolone pulses in severe cases of COVID-19 compared with the standard regimen protocol of dexamethasoneArticle Published on 2022-08-012023-07-08 Journal: Journal of investigative medicine : the official p [Category] COVID19(2023년), [키워드] COVID-19 Glucocorticoids Inflammation Methylprednisolone [DOI] 10.1136/jim-2021-002274 PMC 바로가기
Inactivated vaccines prevent severe COVID-19 in patients infected with the Delta variant: A comparative study of the Delta and Alpha variants from China비활성화된 백신은 Delta 변이에 감염된 환자에서 심각한 COVID-19를 예방합니다: 중국의 Delta 및 Alpha 변이에 대한 비교 연구Article Published on 2022-08-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] addition Alpha variant Antibiotics China Clinical characteristics clinical manifestation clinical manifestations Delta delta variant diagnosed disease dose Efficacy follow-up period generally mild glucocorticoid Glucocorticoids Hospital stay Hospitalization hospitalized patient Inactivated vaccine Inactivated Vaccines Infection information majority Mild MOST outcome Patient Prevent proportion replaced SARS-CoV-2 SARS-COV-2 infection severe COVID-19 vaccination Vaccine widespread Zhejiang [DOI] 10.1002/jmv.27759 PMC 바로가기 [Article Type] Article
Clinical Characteristics of COVID-19: Use of Steroids in Mostly Unvaccinated COVID-19 Patients Before the Omicron VariantCOVID-19의 임상적 특징: Omicron 변이 이전에 대부분 백신을 접종하지 않은 COVID-19 환자에서 스테로이드 사용Article Published on 2022-07-252022-09-11 Journal: Journal of Korean medical science [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval adjusted odds ratio allergy Antibiotics Chain Reaction clinical Clinical data collected Comorbidities Comorbidity concomitant use coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patients demographic Demographic and clinical data described diagnosed with COVID-19 dose electronic medical records enrolled Factor Glucocorticoids groups help high risk hospital independent risk factor independent risk factors Infectious disease initial investigated Lactate lactate dehydrogenase LDH lower dose lymphopenia medication medications moderate moderate to severe Mortality Multivariate analysis omicron Ordinal Scale outlier outliers oxygen Oxygen therapy patients polymerase chain reaction proportion real-time reverse transcription-polymerase chain reaction RECOVERY trial Remdesivir Reverse transcription-polymerase chain reaction risk SARS-CoV-2 scale severe coronavirus disease severity steroid steroid use Steroids subject surrogate markers therapy treated Treatment use of steroids were measured [DOI] 10.3346/jkms.2022.37.e228 PMC 바로가기 [Article Type] Article
Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors성인 COVID-19 생존자에서 감지할 수 있는 상세한 비디오모세혈관경 미세혈관 변화Article Published on 2022-07-012022-09-11 Journal: Microvascular research [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] age Analysis Angiogenesis Capillaries capillary cause change CNT concerning concomitant therapies contrary control group control groups control subject control subjects controls COVID-19 detectable disease disease onset disease severity Effect endothelial cells Endothelial dysfunction evaluate Frequency Giant Glucocorticoids induce less linear Microcirculation Multivariate analysis Nailfold capillaroscopy no statistically significant difference organ damage parameter Patient raynaud s phenomenon Raynaud's phenomenon reduced SARS-CoV-2 scored searched selective significantly significantly lower statistically significant difference survivor Therapies therapy [DOI] 10.1016/j.mvr.2022.104361 PMC 바로가기 [Article Type] Article
The roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysisReview article Published on 2022-07-012022-10-05 Journal: Steroids [Category] 임상, 치료법, [키워드] 95% CI benefit clinical outcomes confidence interval COVID-19 COVID-19 patient COVID-19 patients Efficacy and safety eligible evaluate glucocorticoid Glucocorticoids ICU admission less low-dose mean difference mechanical ventilation Meta-analysis Methylprednisolone Mortality observational studies Patient patients with COVID-19 randomized trial reduced reported risk searched Secondary infection secondary infections severe COVID-19 severe COVID-19 patient subgroup analysis systematic review Treatment ventilator-free day viral shedding Web of Science [DOI] 10.1016/j.steroids.2022.109022 [Article Type] Review article
The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert PanelReview Published on 2022-06-302023-07-09 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), [키워드] Adrenal insufficiency Glucocorticoids hypercortisolism hypothalamic–pituitary–adrenal axis. SARS-CoV-2 [DOI] 10.3390/ijms23137326 PMC 바로가기 [Article Type] Review
Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss Study protocol for a three-armed, randomized, triple-blind, multicenter trial (HODOKORT)article Published on 2022-06-202024-09-02 Journal: HNO [Category] 대상포진, [키워드] Corticosteroids Dexamethasone Glucocorticoids humans idiopathic Prednisolone Randomized controlled trial Steroids Sudden hearing loss [DOI] 10.1007/s00106-022-01184-8 PMC 바로가기 [Article Type] article
Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans아프리카계 미국인을 위한 입원 COVID-19 환자의 사망률에 대한 증상, 임상 및 바이오마커 연관성Article Published on 2022-06-172022-09-11 Journal: BMC Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, [키워드] African African American African Americans age American Analysis analyzed Asian association AST Biomarker Cancer cardiac disease Cohort collected Comorbidities Comorbidity COPD correlated COVID-19 creatinine CRP D-dimer death demographics determine diabetes Diabetes Mellitus diarrhea disease severity elevated elevated liver enzymes Ethnicity European fatigue ferritin focus Frequency Gender Glucocorticoids high mortality Hispanic hospital Hospitalized hospitalized COVID-19 patient hospitalized COVID-19 patients hypertension Immunosuppression increased risk Inflammatory biomarker laboratory data large cohort LAT Latinx liver enzyme liver enzymes Lymphocytes male Male sex mechanical ventilation Mortality mortality rates Multivariate analysis New York non-survivor Older age organ Organ failure outcome outcomes Patient patients hospitalized predictor Prevent procalcitonin progression race required SARS CoV-2 SARS-CoV-2 Sex Shortness of breath significant variable significant variables significantly study population subsequent Symptom troponin [DOI] 10.1186/s12879-022-07520-1 PMC 바로가기 [Article Type] Article
SARS-CoV-2: phenotype, genotype, and characterization of different variantsSARS-CoV-2: 다양한 변이체의 표현형, 유전자형 및 특성화Article Published on 2022-06-172022-09-11 Journal: Cellular & Molecular Biology Letters [Category] COVID19(2023년), SARS, 변종, 치료법, [키워드] ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus Alpha Amino acid amino acid sequence angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 Antibiotics antiviral drugs B.1.1.529 B.1.1.7 B.1.351 B.1.617.2 B.1.621 Beta can not Clusters coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Delta domain eliminated envelope epidemiological data exceptional family Coronaviridae Gamma Genetic variation Genome Genotype Glucocorticoids Health Organization help host cells IFN-α2b Immunoglobulin include infect Infection international public health Intravenous immunoglobulin Lambda membrane Nidovirales nucleocapsid omicron P.1 patients phenotype plasma plasma therapy positive Prevent Protein receptor risk of infection RNA RNA virus SARS-CoV-2 SARS-CoV-2 variants Seven severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Spread structural protein structural proteins subtype the Coronaviridae therapy Transmission treat vaccination Vaccine variant Variation variations VoC WHO World Health Organization [DOI] 10.1186/s11658-022-00352-6 PMC 바로가기 [Article Type] Article